New polypeptide-human Latexin protein 34.65, and polynucleotide for encoding such polypeptide


Application Number: 00125022
Application Date: 2001.01.11
Publication Number: 1364766
Publication Date: 2002.08.21
Priority Information:
International: A61K31/7088;A61K38/16;A61K38/17;A61K39/395;A61P7/00;A61P31/00;A61P31/18;A61P35/00;A61P37/00;C07H21/00;C07K14/00;C07K14/435;C07K16/00;C07K16/18;C12N15/10;C12N15/11;C12N15/12;C12N15/63;C12N15/64;C12P21/00;C12Q1/68;G01N33/68
Applicant(s) Name: Biowindow Gene Development, Inc., Shanghai
Address:
Inventor(s) Name: Mao Yumin;Xie Yi
Patent Agency Code: 00000
Patent Agent:
Abstract The present invention discloses a new kind of polypeptide, human latexin protein 34.65, polynucleotides for encoding this polypeptide and DNA recombination process to produce the polypeptide. The present invention also discloses the method of applying the polypeptide in treating various diseases, such as malignant tumors, hemopathy, HIV Infection, immunological diseases and various inflammations. The present invention also discloses the antagonist resisting the polypeptide and its treatment effect. The present invention also discloses the application of the polynucleotides for encoding human lataxin protein 34.65.